申请人:Merck Patent Gesellschaft mit beschrankter Haftung
公开号:US05434149A1
公开(公告)日:1995-07-18
The present invention relates to thiadiazinones of the formula I ##STR1## having a phosphodiesterase-inhibiting action and which are suitable for combating cardiovascular and asthmatic disorders.
本发明涉及具有磷酸二酯酶抑制作用的公式I的噻二唑酮化合物,适用于治疗心血管和哮喘病症。